274 related articles for article (PubMed ID: 1737688)
1. Bullous diseases in Malaysia: epidemiology and natural history.
Adam BA
Int J Dermatol; 1992 Jan; 31(1):42-5. PubMed ID: 1737688
[TBL] [Abstract][Full Text] [Related]
2. Bullous diseases: a 7-year survey of experience with 77 patients.
Adam BA
Ann Acad Med Singap; 1983 Jan; 12(1):19-25. PubMed ID: 6344741
[TBL] [Abstract][Full Text] [Related]
3. Geographic variations in epidemiology of two autoimmune bullous diseases: pemphigus and bullous pemphigoid.
Alpsoy E; Akman-Karakas A; Uzun S
Arch Dermatol Res; 2015 May; 307(4):291-8. PubMed ID: 25589418
[TBL] [Abstract][Full Text] [Related]
4. Trichoscopy - a useful tool in the preliminary differential diagnosis of autoimmune bullous diseases.
Sar-Pomian M; Rudnicka L; Olszewska M
Int J Dermatol; 2017 Oct; 56(10):996-1002. PubMed ID: 28856676
[TBL] [Abstract][Full Text] [Related]
5. Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study.
Marazza G; Pham HC; Schärer L; Pedrazzetti PP; Hunziker T; Trüeb RM; Hohl D; Itin P; Lautenschlager S; Naldi L; Borradori L;
Br J Dermatol; 2009 Oct; 161(4):861-8. PubMed ID: 19566661
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune bullous dermatoses: a review.
Patrício P; Ferreira C; Gomes MM; Filipe P
Ann N Y Acad Sci; 2009 Sep; 1173():203-10. PubMed ID: 19758152
[TBL] [Abstract][Full Text] [Related]
7. [Pemphigus and pemphigoid].
Stewart WM
Dermatologica; 1980; 160(4):217-35. PubMed ID: 6987108
[TBL] [Abstract][Full Text] [Related]
8. Dermatitis Herpetiformis and Celiac Disease Increase the Risk of Bullous Pemphigoid.
Varpuluoma O; Jokelainen J; Försti AK; Timonen M; Huilaja L; Tasanen K
J Invest Dermatol; 2019 Mar; 139(3):600-604. PubMed ID: 30612975
[TBL] [Abstract][Full Text] [Related]
9. Bullous diseases: Kids are not just little people.
Marathe K; Lu J; Morel KD
Clin Dermatol; 2015; 33(6):644-56. PubMed ID: 26686016
[TBL] [Abstract][Full Text] [Related]
10. Dual diagnosis of Pemphigus and pemphigoid. Retrospective review of thirty cases in the literature.
Sami N; Ahmed AR
Dermatology; 2001; 202(4):293-301. PubMed ID: 11455140
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Autoimmune Bullous Diseases in Elderly Patients in Iran: A 10-Year Retrospective Study.
Ghiasi M; Daneshpazhooh M; Ismonov M; Chams-Davatchi C
Skinmed; 2017; 15(3):175-180. PubMed ID: 28705276
[TBL] [Abstract][Full Text] [Related]
12. [Pemphigus herpetiformis: a clinical variant of pemphigus vulgaris].
Bauer R; Orfanos CE
Hautarzt; 1980 Oct; 31(10):540-4. PubMed ID: 7005184
[TBL] [Abstract][Full Text] [Related]
13. Blistering diseases in the mature patient.
Lakoš Jukić I; Jerković Gulin S; Marinović B
Clin Dermatol; 2018; 36(2):231-238. PubMed ID: 29566927
[TBL] [Abstract][Full Text] [Related]
14. Tetracycline and niacinamide control bullous pemphigoid but not pemphigus foliaceus when these conditions coexist.
Shiohara J; Yoshida K; Hasegawa J; Uhara H; Takata M; Saida T; Ohyama B; Hashimoto T
J Dermatol; 2010 Jul; 37(7):657-61. PubMed ID: 20629832
[TBL] [Abstract][Full Text] [Related]
15. Clinical, pathologic, and immunologic features of pemphigus herpetiformis: a literature review and proposed diagnostic criteria.
Costa LMC; Cappel MA; Keeling JH
Int J Dermatol; 2019 Sep; 58(9):997-1007. PubMed ID: 30900757
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune bullous skin disorders].
Hertl M; Niedermeier A; Borradori L
Ther Umsch; 2010 Sep; 67(9):465-82. PubMed ID: 20806175
[TBL] [Abstract][Full Text] [Related]
17. Frequency of adverse events associated with intravenous immunoglobulin therapy in patients with pemphigus or pemphigoid.
Gürcan HM; Ahmed AR
Ann Pharmacother; 2007 Oct; 41(10):1604-10. PubMed ID: 17785614
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune bullous diseases in non-HIV Kaposi's sarcoma: a retrospective study in a large cohort of patients.
Tourlaki A; Genovese G; Guanziroli E; Scoppio BM; Berti E; Brambilla L
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1777-1783. PubMed ID: 29729120
[TBL] [Abstract][Full Text] [Related]
19. A multicentre prospective analysis of the incidence of pemphigoid diseases in Turkey.
Durdu M; Bozca BC; Enli S; Yazıcı Özgen Z; Yaylı S; Aktan Ş; Mutlu D; Erturan I; Ayvaz Çelik HH; Melikoğlu M; Pala E; Gürsel Ürün Y; Harman M; Şavk E; Işık S; Duygulu Ş; İmren IG; Fettahlıoğlu Karaman B; Kaya Erdoğan H; Kılıç A; Özçelik S; Inan K; Yılmaz MA; Şanlı HE; Kalay Yıldızhan İ; Mülayim MK; Çiçek D; Demir B; Yasak Güner R; Baykal Selçuk L; Gündüz K; Daye M; Borlu M; Solak EO; Dizman D; Güneş B; Ozkur E; Polat M; Eskiocak AH; Uzun S
Australas J Dermatol; 2021 Nov; 62(4):e496-e503. PubMed ID: 34642934
[TBL] [Abstract][Full Text] [Related]
20. When and how to use sulfones in bullous diseases.
Jablonska S; Chorzelski T
Int J Dermatol; 1981 Mar; 20(2):103-5. PubMed ID: 7012048
[No Abstract] [Full Text] [Related]
[Next] [New Search]
